Canary Advisors, an industry leader in patient engagement, today announced the launch of Canary Concierge, a personalized ...
Medidata Patient Experience will accelerate CTI’s treatments for patients with oncology, metabolic, cardiovascular, central ...
In this episode presented by PII, BioSpace’s head of insights discusses how to relieve clinical trial patients of ...
Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...
This investment will improve the healthcare experience for patients, reinforcing Dassault Systèmes’ role in the industry’s transformation Click Therapeutics will gain access to Dassault Systèmes’ ...
Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...
What happens to a patient after I refer them to a clinical trial? Do they leave my practice? Referring patients to a clinical trial is similar to referring them to a specialist. They remain your ...
The Lupus Research Alliance (LRA), through its Lupus Accelerating Breakthroughs Consortium (Lupus ABC)—a public-private ...
James is a pulmonary and critical care physician specializing in sarcoidosis. When one of my patients was first diagnosed with sarcoidosis, her specialist gave her two options: take steroids or join a ...
Roughly 70 to 80% of ovarian cancer cases are diagnosed at an advanced stage,1 where treatment options are limited and ...
The agency might dissuade patients from participating in a crucial part of our research-and-development system.
The FDA previously placed two clinical studies on hold, including the Phase III trial in which the liver toxicity occurred.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results